Latent tuberculosis infection: the 4-month course of rifampicin is safer than the 9-month course of isoniazid
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
Rédigé par : Pr Pierre Tattevin
Different regimens have similar efficacy for the treatment of latent tuberculosis infection (LTI), including 3 months of isoniazid (INH)/rifampicin (RMP), 4 months of RMP, and 9 months of INH. Hence, tolerability is a major criteria to define the optimal regimen.
Results
In this post-hoc analysis of 2 open-label randomized trials comparing 4 months of RMP and 9 months of ...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.